Elizabeth Holland is a Senior Research Scientist in the melanoma genetic epidemiology laboratory at the Westmead Institute for Medical Research (WIMR), coordinating biological samples and genotyping for melanoma studies including the high-risk melanoma family study and the Australian Melanoma Family Study in collaboration with the melanoma genetics (GenoMEL) consortium. Recently, she has helped develop a risk prediction model for estimating the presence of a high-risk CDKN2A mutation, and is establishing a linked dataset for the high-risk family study.